A Guide To Medications That Can Trigger Psoriatic Arthritis

Some common prescriptions can worsen psoriasis and, in susceptible people, may help trigger psoriatic arthritis symptoms.

This guide explains five medications tied to flares, how to spot early signs, when to see a doctor, and the most-used treatments—so you can make informed, safe decisions with your care team.

5 medications that may trigger psoriatic arthritis

Strictly speaking, no drug is known to directly “cause” psoriatic arthritis (PsA). But several medicines are associated with psoriasis flares or immune shifts that can unmask or intensify joint symptoms in those with psoriasis or a family history of it. See background on psoriasis triggers from the NHS at nhs.uk and PsA basics from the American College of Rheumatology at rheumatology.org.

Important: the overall risk is uncommon, and these medicines are life‑saving for many conditions. Never stop a prescription without speaking to your prescriber. If new joint pain, swelling, or prolonged morning stiffness begins soon after a medication change, call your clinician—there are often safe alternatives or strategies to reduce risk.

How might medicines set off symptoms? The leading theories involve shifts in innate and adaptive immunity (for example, Th17/IL‑23 pathways) and changes in skin barrier or microbiome that, in genetically predisposed people, tip the balance toward psoriatic disease.

• Beta‑blockers (e.g., propranolol, metoprolol): Linked to onset or worsening of psoriasis in some patients, which can precede or coincide with PsA. If you develop new plaques or joint pain after starting a beta blocker, ask about alternatives such as calcium‑channel blockers.
• Lithium (for bipolar disorder): A classic trigger of psoriasis exacerbations; flares may be dose‑related and can appear weeks after initiation. Discuss risks and skin monitoring if you use lithium; dermatology and psychiatry can often coordinate safer plans.
• Antimalarials (chloroquine, hydroxychloroquine): These can induce or worsen psoriasis in susceptible individuals. If needed for rheumatic disease, clinicians often watch closely for skin or joint changes.
• Interferons (e.g., interferon‑alpha for viral hepatitis): Interferon signaling can up‑regulate pathways involved in psoriatic inflammation; new or worsening plaques and arthritic symptoms are reported in some patients on interferons.
• Terbinafine (oral antifungal): Rarely, terbinafine is associated with psoriasis exacerbation. Consider topical antifungals or different systemic options if you have psoriatic disease.

Other medicines occasionally reported include ACE inhibitors and withdrawal from systemic corticosteroids; however, risks vary and must be weighed against benefits. If you’re worried about medications that can cause or trigger psoriatic arthritis symptoms, bring a complete list of your drugs and timing of symptom changes to your appointment.

Early signs and common symptoms

About a third of people with psoriasis eventually develop PsA, and joint issues can start subtly. Review the condition overview at MedlinePlus and the ACR patient page noted above. Watch for:

• Persistent morning stiffness (often >30 minutes) that improves as the day goes on.
• Swelling of entire fingers or toes (dactylitis), sometimes called “sausage digits.”
• Tender spots where tendons/ligaments attach to bone (enthesitis), commonly at the heel or bottom of the foot.
• Nail changes such as pitting, crumbling, or lifting from the nail bed (nail psoriasis).
• Asymmetric joint pain and swelling, often in a few joints at first (hands, feet, knees), sometimes with low back or buttock pain if the spine or sacroiliac joints are affected.
• Skin flares that coincide with joint symptoms, or vice versa.
• Eye symptoms like painful red eye and light sensitivity, which can signal uveitis—an inflammation sometimes associated with PsA.
• Fatigue, low mood, or sleep disturbance related to chronic inflammation and pain.

Medication‑related psoriatic flares often appear within weeks to a few months of starting or increasing a drug. Keep a simple symptom diary with dates of medication changes, and take photos of any new rashes to show your clinician.

When to see a doctor

Contact your primary care clinician or dermatologist promptly if you notice:

• Joint swelling and stiffness lasting more than a few days, especially after a new medication is started.
• Whole‑finger or toe swelling, heel pain that makes walking difficult, or new nail lifting/pitting.
• Eye pain/redness with light sensitivity (possible uveitis).
• Fever, inability to bear weight, or severe pain—seek urgent care.

Early diagnosis matters: uncontrolled inflammation can damage joints within months. Ask for referral to a rheumatologist (PsA specialist) if symptoms persist or if you already carry a psoriasis diagnosis. Bringing a timeline of medication changes and symptoms helps the specialist decide whether a drug is contributing.

Popular treatment options for psoriatic arthritis

Good news: most people achieve meaningful relief and protect their joints with modern therapy. Treatment is individualized based on severity, pattern of joint involvement, skin disease, and coexisting conditions.

Relief and protection

• NSAIDs for pain and stiffness, such as ibuprofen or naproxen. These help symptoms but do not prevent joint damage. Learn more about NSAIDs.
• Local corticosteroid injections for a few troublesome joints or tendon insertions (administered by a clinician). See the concept of intra‑articular injection. Avoid abrupt withdrawal of systemic steroids if used for another condition—this can provoke severe skin flares.

Disease‑modifying medicines

• Conventional synthetic DMARDs: methotrexate, leflunomide, and sulfasalazine help control joints and, for methotrexate, often improve skin.
• Biologics: agents targeting TNF (TNF inhibitors), IL‑17 (IL‑17 inhibitors), and IL‑12/23 or IL‑23 (IL‑23 pathway) reduce inflammation and protect joints.
• Targeted synthetic DMARDs: JAK inhibitors and the PDE4 inhibitor apremilast are options, especially when injections aren’t preferred.

Whole‑person care

• Address comorbidities (weight, blood pressure, lipids). Weight management and smoke‑free living improve outcomes and medication response.
• Stay current on vaccines before starting immunosuppressive therapy; review adult schedules at the CDC.
• Physical and occupational therapy to maintain mobility, protect joints, and optimize daily function. Learn about physical therapy.
• Skin care coordination with dermatology, since clearing the skin often helps joint symptoms and quality of life.

Key takeaways

• A handful of medications—beta‑blockers, lithium, antimalarials, interferons, and terbinafine—have been linked to psoriasis flares that can coincide with psoriatic arthritis symptoms.
• Don’t stop prescriptions on your own. If symptoms start after a new drug, talk to your clinician about risks, alternatives, and monitoring.
• Early signs include morning stiffness, dactylitis, enthesitis, nail changes, and asymmetric joint swelling—seek evaluation early to protect joints.
• Modern DMARDs and biologics, plus lifestyle and rehab strategies, help most people reach low disease activity or remission.